🔒 Confidential · Pre-Series A · 2026
📈 Investor Briefing
Raising ₹8 Cr

Pre-Series A round to build India’s first ABDM-native multi-stakeholder health intelligence network — connecting hospitals, insurers, pharma, pharmacies, diagnostics, doctors, and patients on a single consent-governed FHIR R4 data layer.

✓ ABDM mandate tailwind ✓ 7 revenue streams ✓ ₹42 Cr ARR Yr 3 ✓ 18–24 mo cert moat
UHIN ECOSYSTEM — INVESTMENT THESIS ABHA IDENTITY 🏥Hospitals 🛡Insurance 💊Pharma 🔬Diagnostics 🏪Pharmacy 👨‍⚕Doctors 🪐Patients ₹42 Cr ARR • Year 3 Target FHIR R4 • ABDM HIP/HIU • DPDP 2023 • India Data Residency
The Ask

₹8 Crore Pre-Series A — use of funds

Every rupee is allocated to a specific Phase 1 (0–12 month) deliverable. The round closes with 3 hospitals live and ₹2 Cr ARR signed.

40% of round
₹3.2 Cr
Technology Build
Core platform infrastructure for Phase 1
  • HAPI FHIR server + NRCeS profiles
  • 11 ABDM API callbacks (HIP + HIU)
  • Hospital OPD 5-screen workflow
  • Consent engine + 3-identifier ABHA lookup
  • AWS Mumbai infra + per-patient KMS
  • CERT-In WASA security audit
35% of round
₹2.8 Cr
Team Hiring
8 critical roles — Month 1 to Month 6
  • CTO / Lead Architect (FHIR + ABDM)
  • ABDM Integration Lead (HIP/HIU)
  • Clinical Informatics Lead (MBBS + IT)
  • Full-stack Engineers ×3
  • Hospital Onboarding Lead
  • Security & Compliance Lead
25% of round
₹2.0 Cr
Pilots & Compliance
Hospital pilots + ABDM certification
  • 3 Telangana pilot hospitals
  • NHA ABDM HIP/HIU certification
  • Legal: MCA registration, IP, contracts
  • DPIIT recognition + BIRAC BIG filing
  • THM partnership MoU
  • ABDM sandbox exit + NHA panel demo
₹4.2L
ACV per hospital
₹35k/mo × 12
₹85k
CAC per hospital
sales + onboarding
₹21L
LTV (5-yr)
68% gross margin
6–8 mo
CAC Payback
vs 12–18 mo benchmark
68%
Blended Gross Margin
SaaS + analytics
120%+
NRR Target
via upsell expansion
Revenue Model

7 revenue streams — SaaS + data licensing

SaaS subscriptions anchor the model; analytics licensing scales with zero marginal cost. Target blended gross margin: 68–72%.

Revenue StreamModelPrice RangeYr 1Yr 3 ARR
Hospital & Clinic SaaSSubscription₹15k – ₹80k /mo20 facilities₹18 Cr
Doctor SaaS (per-seat)Per seat₹2k – ₹8k /seat100 seats₹6 Cr
Insurance API LicensingAPI calls₹2 – ₹8 /call1 pilot₹8 Cr
Pharma Analytics LicenceAnnual lic.₹50L – ₹2 Cr2 cos₹12 Cr
Pharmacy AnalyticsSubscription₹5L – ₹25L₹4 Cr
Diagnostics AnalyticsSubscription₹3L – ₹15L₹2 Cr
Total ARR₹2 Cr₹50 Cr
Yr 3 ARR by stream
Subscription Pricing

Simple tiers — built for India's healthcare economics

A hospital paying ₹35,000/month that eliminates ₹3–5 Cr/year in duplicate diagnostics sees 700× ROI on their UHIN subscription.

Clinic
₹15k/mo
Up to 3 doctors
  • OPD ABHA module
  • e-Prescription + DSC
  • Cross-facility history
  • ABDM HIP/HIU
Tertiary / Chain
₹80k/mo
Per facility
  • Multi-facility dashboard
  • Custom EMR integration
  • Dedicated CSM
  • 99.9% SLA
  • White-label option
Independent Doctor
₹2k/seat/mo
Per doctor/month
  • Full ABHA history
  • NMC e-Prescription
  • Location intelligence
  • Practice analytics
Hospital pays UHIN
₹4.2L/yr
Hospital saves / earns
₹3–5 Cr/yr
Hospital ROI
700×
Phased Delivery

4 phases — 24 months to national scale

Each phase has defined milestones, revenue targets, and the specific outcomes needed to de-risk the next phase. Phase 1 is fully funded by this round.

1

Foundation

Month 1 – 6
HAPI FHIR server + NRCeS profiles
All 11 ABDM APIs in sandbox
Hospital OPD module (5-screen)
ABHA lookup: Aadhaar/ABHA/mobile
e-Prescription with DSC
3 pilot hospitals — Telangana
CERT-In WASA security audit
🎊 M1: ABDM certification filed
2

Interop Scale

Month 7 – 12
ABDM HIP/HIU production creds
Insurance pre-auth API (1 insurer)
3-state data corridor live
50+ hospitals onboarded
Consent engine v2 (full M3)
NHCX claims integration
Rural ABHA registration camps
🎊 M2: ₹2 Cr ARR signed
3

Analytics Platform

Month 13 – 18
Pharma analytics module live
Pharmacy intelligence module
Diagnostics ROI module
Data analytics marketplace
200+ hospitals · 5 pharma cos
de-identified analytics pipeline
Doctor location intelligence
🎊 M3: ₹10 Cr ARR milestone
4

National Scale

Month 19 – 24
AI clinical decision support
Rural offline PHC app (ASHA)
UHI service discovery layer
500+ hospitals nationally
Multi-state government MoUs
WhatsApp ABHA bot — 10 langs
Series A ready at Month 20–22
🎊 M4: ₹42 Cr ARR · Series A+
Financial Projections

ARR trajectory — Month 1 to Year 3

Annual Recurring Revenue (ARR)
Conservative estimates · 30% discount vs SaaSBoomi India benchmarks · 68% gross margin
Key Financial Metrics
68%
Blended gross margin
SaaS + analytics blend
<18 mo
Payback period
per hospital customer
3:1
LTV : CAC ratio
industry benchmark
Burn & Runway
₹8 Cr round gives 12 months runway at ₹67L/month burn rate. Revenue from Month 4 (first hospital live). Break-even projected at Month 16–18.
Series A Trigger
₹10 Cr ARR + 200 hospitals + 3-state corridor live — target raise of ₹35–50 Cr at 4–6× ARR multiple at Month 20–22.
Year 3 Valuation Basis
₹42 Cr ARR × 5–8× revenue multiple = ₹210–336 Cr valuation (US$25–40M). Comparable India healthtech SaaS cos traded at 4–9× at Series B.
Unit Economics

Per-customer economics — hospital SaaS

₹4.2L
ACV (avg hospital)
₹35k/mo × 12
₹85k
CAC per hospital
sales + onboarding cost
₹21L
LTV (5-yr)
ACV × 5 × 68% GM
6–8 mo
CAC payback
vs 12–18mo benchmark
Why churn is structurally low
ABDM care contexts, patient records, and care history are anchored to UHIN. Switching means losing institutional health data continuity.
OPD workflows are embedded in daily clinical routines. Hospital staff habit formation within 60 days of go-live.
ABDM HIP registration is tied to UHIN’s Client ID. Re-certification with another vendor takes 6–12 months.
Network effects: every new hospital joining makes the platform more valuable for all existing hospitals.

5-year revenue model per hospital

Year Revenue Gross Profit Expansion
Net Revenue Retention target
NRR target 120%+ — expansion via IPD module, insurance add-on, and analytics upsell. Industry benchmark for best-in-class B2B SaaS: 115–125% (KeyBanc 2024).
Scalability

How UHIN scales without proportional cost growth

UHIN’s architecture is designed for marginal-cost-near-zero scaling. Adding a new hospital costs ₹5,000–8,000 in onboarding effort. Adding a new pharma analytics customer costs near zero (data is already collected).

☁️

AWS auto-scaling infra

HAPI FHIR server and RDS PostgreSQL on AWS Auto Scaling Groups. Additional 10,000 patients = <₹200/month incremental infrastructure cost. Kafka event streaming handles 10× traffic spikes without pre-provisioning.

📈

Data flywheel — zero marginal cost analytics

Every hospital that joins generates data that makes pharma, insurance, and diagnostic analytics more valuable. Adding a 10th pharma analytics customer costs zero in infrastructure — the data lake is already built.

👥

Network effects lock-in

Each new hospital makes the platform more valuable to every other hospital (shared cross-facility history), every insurer (larger claims dataset), and every pharma customer (larger prescription analytics sample).

🧑‍⚕️

ABDM as a growth engine

The NHA mandate creates inbound demand. Hospitals under AB-PMJAY compliance pressure are actively seeking ABDM-certified partners. UHIN doesn’t need to generate demand — it needs to capture existing government-mandated demand.

🌎

Replicable state playbook

Telangana pilot creates a replicable state-by-state playbook: state health authority MoU → 20–30 pilot hospitals → PHC ABHA camps → scale to 200+ facilities. Each state takes 6–9 months after the first.

🔒

ABDM certification moat

18–24 months for any new entrant to complete HIP/HIU certification + CERT-In WASA + NHA panel demo. UHIN’s 12–18 month head start is a structural advantage that compounds as hospitals lock in.

Market Sizing
TAM
₹4.2L Cr
India digital health total addressable market by 2030
FICCI-EY Vision 2030 · IBEF 2024
SAM
₹18,000 Cr
ABDM-mandated hospitals + insurers + pharma companies (reachable via UHIN)
36,229 hospitals × ₹30k avg + insurance + pharma
SOM (Yr 3)
₹42 Cr
500 hospitals + 12 pharma cos + 1 major insurer + pharmacy/diagnostics chains
0.23% of SAM — highly conservative capture
Competitive Landscape

Why no existing player competes directly

UHIN’s unique position is the combination of multi-stakeholder + ABDM-native + analytics layer. No existing player has all three.

Player / Type ABDM native? Multi-stakeholder? Analytics layer? India data residency? Where they fall short
★ UHIN ✓ HIP+HIU ✓ 7 stakeholders ✓ All layers ✓ AWS Mumbai
Hospital EMR vendors (e.g. Medinous, eSushrut) Partial ✗ Hospital only ✗ None ✓ Yes Single-stakeholder, no analytics, no ABDM-native M3
Insurance claim platforms (e.g. Ekincare, Medi Assist) ✗ No Insurance only Claims only ✓ Yes No ABHA consent layer, no clinical records, no hospital module
Health data platforms (e.g. Innovaccer India) Partial Partial ✓ Strong Partial US-focused, high price point, not built for ABDM consent framework
Pharma data vendors (e.g. IQVIA, AIOCD) ✗ No ✗ Pharma only ✓ Pharma ✗ Mixed No ABDM integration, no patient consent layer, no hospital workflow
Large IT cos (TCS, Wipro health) Building In planning Planned ✓ Yes Enterprise sales cycles (24–36 mo), not accessible to mid-market hospitals, high TCO
🔓
18–24 month certification moat

ABDM HIP/HIU certification requires NHA audit, FHIR conformance testing, CERT-In WASA report, and live NHA panel demo. Any new entrant faces the same timeline. UHIN’s head start is a structural, time-gated barrier.

👥
Data network effects

Every facility joining UHIN makes the dataset richer for every other stakeholder. Pharma analytics improves. Insurance risk models improve. This creates a compounding moat that grows with every new hospital onboarded.

🍁
Government mandate tailwind

The NHA ABDM mandate for all AB-PMJAY hospitals isn’t a market to create — it’s a regulatory queue. 36,229 hospitals must comply. UHIN captures inbound demand without spending on demand generation.

🔒
Workflow embedding lock-in

Within 60 days of go-live, UHIN’s OPD workflow becomes the primary clinical tool for hospital staff. Switching requires re-training the entire OPD team and re-registering ABDM credentials — a 6–12 month process.

Target Investors

Who we are raising from

🏥

Healthtech VCs

Investors who understand ABDM’s structural role and have a healthcare-specific thesis for India.
✓ Healthquad (preferred lead)
✓ pi Ventures
✓ Chiratae Ventures
✓ Ankur Capital (rural focus)
💰

SAFE / Angel Rounds

Fast-moving angels who want early access to India’s health data infrastructure layer.
✓ 100X.VC (India-first SAFE)
✓ Indian Angel Network (IAN)
✓ Hyderabad Angels
✓ iSPIRT philanthropyCircle
🏗️

Non-dilutive Grants

Government and foundation grants aligned with ABDM mission and rural health outcomes.
✓ BIRAC BIG — ₹50L (filing)
✓ MeitY Startup Hub
✓ DPIIT recognition — tax benefits
✓ NHA DHIS incentives
Deliverables with this round

What ₹8 Cr buys by Month 12

ABDM HIP/HIU certification completed + production credentials
3+ hospitals live on UHIN in Telangana with real patient data flowing
First cross-facility patient record transfer demonstrated on live system
First insurance company API integration live in pilot
₹2 Cr ARR signed contracts from hospitals + 1 insurer + 1 pharma co
Series A raise-ready package at Month 12–14
Why now

The 12–18 month window

India’s health data infrastructure moment is now. The ABDM mandate is creating urgency. The infrastructure exists. The patient demand is real. The window before large enterprise players fully enter this space is 12–18 months.

🌍 Government mandate creating urgency
ABDM compliance is becoming mandatory for AB-PMJAY hospitals. Bihar has started enforcement. Other states will follow in 2026.
⌛ ~85 Cr ABHA IDs — user infrastructure ready
The patient-side infrastructure already exists. UHIN doesn’t need to create demand — it just needs to connect existing identity to existing hospitals.
📈 India HealthTech raised $828M in H1 2025
India’s healthtech sector was the 2nd most funded startup vertical in H1 2025. Investor appetite for infrastructure-layer health plays is at an all-time high.
👨‍💻 Founding team window is now
The combination of ABDM mandate urgency + available founding team + Telangana pilot relationships + investor appetite makes March 2026 the optimal raise moment.
Request Investment Materials

Ready to discuss UHIN?

We share the full financial model, architecture reference, ABDM integration roadmap, and pilot hospital term sheets under NDA. Contact us to schedule a technical deep-dive or investor call.

Request Full Deck + NDA ABDM Compliance Page Technical Architecture
Confidential · Pre-Series A · March 2026 · Hyderabad, Telangana, India · DPIIT recognition pending